PDF-Commissioning Policy
OFFICIAL
1
Clinical
Tocilizumab for the treatment of adult onset Stills disease refractory to second line therapy adults 21
08
01P URN 1609 First p
ublished June
20
18
Updated
Download Presentation
"Commissioning Policy" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.